Clarke Inc.
CLKFF
$17.34
$7.8081.81%
| Weiss Ratings | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | C | |||
| Rating Factors | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.11 | |||
| Price History | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 81.81% | |||
| 2-Year Total Return | 105.27% | |||
| 3-Year Total Return | 108.92% | |||
| 5-Year Total Return | 113.60% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $17.34 | |||
| 52-Week Low Price | $17.34 | |||
| 52-Week Low Price (Date) | Oct 15, 2024 | |||
| 52-Week High Price (Date) | Oct 15, 2024 | |||
| Valuation | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 215.04M | |||
| Enterprise Value | 342.46M | |||
| Price/Earnings (TTM) | 13.90 | |||
| Earnings Per Share (TTM) | 1.25 | |||
| Earnings Per Share Growth | -956.49% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.99 | |||
| Price/Book (Q) | 1.28 | |||
| Enterprise Value/Revenue (TTM) | 5.80 | |||
| Price | $17.34 | |||
| Enterprise Value/EBITDA (TTM) | 14.59 | |||
| Enterprise Value/EBIT | 21.37 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 13.95M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $1.59 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $1.59 | |||
| Company Info | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 902-442-3000 | |||
| Address | 145 Hobsons Lake Drive Halifax, NS B3S 0H9 | |||
| Website | www.clarkeinc.com | |||
| Country | Canada | |||
| Year Founded | 1997 | |||
| Profitability | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 27.13% | |||
| Profit Margin | 28.86% | |||
| Management Effectiveness | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.02% | |||
| Return on Equity | 10.06% | |||
| Income Statement | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 53.85M | |||
| Total Revenue (TTM) | 60.64M | |||
| Revenue Per Share | $4.35 | |||
| Gross Profit (TTM) | 29.27M | |||
| EBITDA (TTM) | 24.10M | |||
| EBIT (TTM) | 16.46M | |||
| Net Income (TTM) | 17.51M | |||
| Net Income Avl. to Common (TTM) | 17.51M | |||
| Total Revenue Growth (Q YOY) | 3.43% | |||
| Earnings Growth (Q YOY) | 743.74% | |||
| EPS Diluted (TTM) | 1.25 | |||
| EPS Diluted Growth (Q YOY) | 745.25% | |||
| Balance Sheet | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 968.20K | |||
| Cash Per Share (Q) | $0.07 | |||
| Total Current Assets (Q) | 7.62M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 189.22M | |||
| Current Ratio (Q) | 0.203 | |||
| Book Value Per Share (Q) | $13.56 | |||
| Total Assets (Q) | 347.49M | |||
| Total Current Liabilities (Q) | 37.60M | |||
| Total Debt (Q) | 123.28M | |||
| Total Liabilities (Q) | 158.27M | |||
| Total Common Equity (Q) | 189.22M | |||
| Cash Flow | CLKFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -37.34M | |||
| Cash from Financing (TTM) | 26.51M | |||
| Net Change in Cash (TTM) | 233.40K | |||
| Levered Free Cash Flow (TTM) | 72.00M | |||
| Cash from Operations (TTM) | 11.06M | |||
